ThermoGenesis Holdings Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Chris Xu
Chief executive officer
US$699.0k
Total compensation
| CEO salary percentage | 74.2% |
| CEO tenure | 6.9yrs |
| CEO ownership | n/a |
| Management average tenure | 6.6yrs |
| Board average tenure | 6.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$14m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$699k | US$519k | -US$11m |
| Sep 30 2022 | n/a | n/a | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$11m |
| Dec 31 2021 | US$748k | US$500k | -US$11m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$2m | US$505k | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$18m |
| Jun 30 2020 | n/a | n/a | -US$17m |
| Mar 31 2020 | n/a | n/a | -US$12m |
| Dec 31 2019 | US$472k | US$472k | -US$9m |
| Sep 30 2019 | n/a | n/a | -US$13m |
| Jun 30 2019 | n/a | n/a | -US$13m |
| Mar 31 2019 | n/a | n/a | -US$39m |
| Dec 31 2018 | US$653k | US$460k | -US$40m |
| Sep 30 2018 | n/a | n/a | -US$32m |
| Jun 30 2018 | n/a | n/a | -US$32m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | US$1m | US$216k | -US$6m |
Compensation vs Market: Chris's total compensation ($USD699.00K) is above average for companies of similar size in the German market ($USD417.54K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Xu (52 yo)
6.9yrs
Tenure
US$699,000
Compensation
Dr. Xiaochun Xu, also known as Chris, M.B.A. Ph D., is the Founder, Chairman and Chief Executive Officer of Boyalife Group since July 2009.He serves as an Advisor at WI Harper Group. Dr. Xu has been the C...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.9yrs | US$699.00k | no data | |
| CFO & Corporate Secretary | 6.6yrs | US$325.00k | 0.00064% $ 21.6 | |
| COO & Director | 5.8yrs | US$554.00k | 0% $ 0 |
6.6yrs
Average Tenure
52yo
Average Age
Experienced Management: THRP's management team is seasoned and experienced (6.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 7.6yrs | US$699.00k | no data | |
| COO & Director | 1.8yrs | US$554.00k | 0% $ 0 | |
| Independent Director | 6.7yrs | US$54.50k | 0% $ 0 | |
| Member of Clinical & Scientific Advisory Board | 9.4yrs | no data | no data | |
| Member of Clinical Advisory Board | 7.6yrs | no data | no data | |
| Independent Director | less than a year | US$99.00k | no data | |
| Independent Director | 6.8yrs | US$56.00k | 0% $ 0 | |
| Independent Director | less than a year | no data | no data |
6.7yrs
Average Tenure
57yo
Average Age
Experienced Board: THRP's board of directors are considered experienced (6.7 years average tenure).